Freedom Capital Markets analyst Paul Meeks upgraded Cerebras Systems (CBRS) to Buy, maintaining a $209 price target, despite recent stock declines driven by concerns over Nvidia's dominance. Meeks argues that competition from Nvidia is overstated, citing Cerebras's specialization in AI inference and strong partnerships, suggesting significant growth potential.
Cerebras Systems (CBRS) shares recently tanked due to investor concerns that OpenAI is favoring Nvidia (NVDA) GPUs. However, Freedom Capital Markets analyst Paul Meeks upgraded CBRS to Buy, arguing that the Nvidia competition is 'exaggerated' and a 'minor threat.' Meeks believes Cerebras's specialization in AI inference and partnerships with AMD and AWS position it for significant revenue growth, despite Nvidia's role in the 'prefill' phase. This analyst upgrade aims to alleviate short-term investor fears, potentially providing a floor for CBRS stock, but the long-term success hinges on the company's ability to scale capacity efficiently and manage execution risks.